Normal Saline for Parenteral Use Market Reached USD 3.24 Billion in 2022; Growing Uptake of Normal Saline for Dehydration and Sepsis to Bolster the Market Growth

The global normal saline for parenteral use market size stood at USD 3.24 billion in 2022. The market value is slated to rise from USD 3.44 billion in 2023 to USD 5.48 billion by 2030 at a CAGR of 6.9% during 2023-2030. Fortune Business Insights™ presents this information in its report, titled “Normal Saline for Parenteral Use Market Size, Share & COVID-19 Impact Analysis, By Type (Plastic Bottles and Glass Bottles), By Application (Intramuscular Injection and Intravenous Injection), and Regional Forecast, 2023-2030” The expansion can be credited to the surging demand for saline owing to the flu season. Amid the flu season, IV saline solutions, which are deployed to provide hydration and medications to hospitalized patients, witness high demand. Moreover, flu-related hospital admissions are due to the severe complications caused by flu seasons, with H3N2 identified as the major Influenza A virus strain than H1N1.

Decline in the Demand for IV Fluids During Pandemic Had a Negative Impact on Market Growth

The demand for IV fluids, such as normal saline, observed a decrease due to the reduction in the number of surgeries during the pandemic. In addition, the pandemic witnessed fewer hospitalizations attributed to the reduction in patient visits to care centers and specialty clinics. Thus, these factors hindered the market expansion during the COVID-19 pandemic.

B. Braun Medical Announced its Plan to Invest in New Facility to Address IV Shortage

In May 2019, B. Braun Medical unveiled its decision to invest USD 1 billion into new and existing IV fluid production facilities to address the shortage of IV solutions caused by Hurricane Maria, which led to landfall in Puerto Rico in 2017. The company also announced to build a supply network by inaugurating a new distribution facility in Daytona Beach. This development helped the company expand its geographical footprint.

Market Value to Grow Owing to Surging Use of Normal Saline for Dehydration and Sepsis

The market growth is driven by a growth in the uptake of normal saline for sepsis and dehydration. Saline is the preferred IV fluid in hospitals for managing different conditions, including diarrhea, dehydration, vomiting, and managing fluid resuscitation in different severe conditions.

However, studies recommending the use of balanced fluids in place of saline may hamper the market growth.

Leading Market Players Deploy Mergers and Acquisition Strategies to Reinforce their Position

The major normal saline for parenteral use market players are focusing on different competitive strategies to expand their industry hold. Several companies are investing huge amounts into mergers and acquisition strategies to capture the largest market share. Other strategic initiatives include partnerships, product innovations, joint ventures, and others.

List of Key Players Profiled:

• Baxter (U.S.)
• Kelun Group (China)
• B. Braun Melsungen AG (Germany)
• Fresenius Kabi AG (Germany)
• SSY Group Limited (China)
• ICU Medical (U.S.)
• Double-Crane Pharmaceutical Co., Ltd. (China)
• Otsuka Pharmaceutical Co., Ltd. (Japan)
• Cisen Pharmaceutical Co., Ltd. (China)
• Pharmally International Holding Co., Ltd. (China)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/normal-saline-for-parenteral-use-market-104520

Key Industry Development

July 2019- Eurolife Healthcare Pvt Ltd, a manufacturer of specialty pharmaceuticals, completed the acquisition of Israel-based Teva's intravenous infusion (IV) unit in Hungary. This move aimed to help the company expand its presence in the U.S. and Europe.

Further Report Findings

• North America market held the largest share in 2022. The strong presence of key market players is impelling the regional growth.
• The Asia Pacific market is expected to emerge as the second leading region during the forecast period, owing to the growing number of hospitalizations.
• By type, the market is divided into glass bottles and plastic bottles. The plastic bottles segment is poised to register the largest normal saline for parenteral use market share during the forecast period. The growing collaboration deals for IV fluids are proliferating the segment growth.
• By application, the market is segmented into intravenous injection and intramuscular injection. The intravenous segment registered the largest market share in 2022. The growing preference for intravenous injection for normal saline is fueling the segment growth.

Table of Segmentation